VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 134 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $423,000 | -27.2% | 32,202 | -46.4% | 0.10% | -15.6% |
| Q3 2020 | $581,000 | +60.1% | 60,134 | +89.4% | 0.12% | +69.4% |
| Q2 2020 | $363,000 | -99.9% | 31,748 | -16.6% | 0.07% | +24.1% |
| Q3 2017 | $681,543,000 | +9.8% | 38,075 | 0.0% | 0.06% | +1.8% |
| Q2 2017 | $620,623,000 | -29.7% | 38,075 | -39.6% | 0.06% | -34.5% |
| Q1 2017 | $883,078,000 | – | 63,077 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |